Skip to main content

Exploring Funding Opportunities for Diverse Founders and Executives

October 18, 2023
Imperial Ballroom
A Nature biotechnology report cited an analysis of the 25 most active VC firms that shows less than 1% of senior level investment teams have partners from underrepresented racial and ethnic groups. McKinsey data also shows disparities in funding women's health outside of oncology with less than 2 percent of the current healthcare pipeline including these conditions despite women being half of the global population. Attend this session to hear how VCs, diverse founders, and biotech executives are approaching investment opportunities to reduce these disparities.
Stanley Lewis, Founder and CEO - A28 Therapeutics
Andy Schwab, Founder and Managing Partner - 5AM Ventures
Anula Jayasuriya, Founder & Managing Director - EXXClaim Capital